Garenoxacin/magnesium sulfateLack of efficacy and Torsades de pointes secondary to worsening of QT interval prolongation: case report

被引：0

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1808卷 / 1期

关键词：

D O I：

10.1007/s40278-020-79607-z

中图分类号：

学科分类号：

摘要：

引用

页码：130 / 130

共 50 条

[21] MethadoneTorsades de pointes secondary to QT prolongation: case report
Reactions Weekly, 2020, 1806 (1) : 181 - 181
[22] Induced QT prolongation and torsades de pointes
Yap, YG
Camm, AJ
HEART, 2003, 89 (11) : 1363 - 1372
[23] Donepezil - QT prolongation and torsades de pointes
Malik, Bilal Haider
CLINICAL MEDICINE, 2019, 19 (02) : 189 - 189
[24] QT interval prolongation and torsades de pointes in a patient undergoing treatment with vorinostat: A case report and review of the literature
Lynch, Donald R., Jr.
Washam, Jeffrey B.
Newby, L. Kristin
CARDIOLOGY JOURNAL, 2012, 19 (04) : 434 - 438
[25] MethadoneTorsades de pointes due to QT interval prolongation: case report
Reactions Weekly, 2013, 1463 (1) : 24 - 24
[26] HydroxyzineSyncope, QT interval prolongation and torsade de pointes: case report
Reactions Weekly, 2009, 1245 (1) : 20 - 21
[27] AmiodaroneTorsades de pointes and QT-interval prolongation: case report
Reactions Weekly, 2018, 1722 (1) : 29 - 29
[28] QT interval prolongation and Torsades de Pointes in a patient receiving zolpidem and amiodarone
Letsas, KP
Filippatos, GS
Kounas, SP
Efremidis, M
Sideris, A
Kardaras, F
CARDIOLOGY, 2006, 105 (03) : 146 - 147
[29] Torsades de pointes complicating complete heart block with QT interval prolongation
Stankovic, Ivan
Putnikovic, Biljana
Neskovic, Aleksandar N.
ACTA CARDIOLOGICA, 2016, 71 (05) : 627 - 627
[30] QT INTERVAL PROLONGATION AND TORSADES-DE-POINTES DUE TO ERYTHROMYCIN LACTOBIONATE
OBERG, KC
BAUMAN, JL
PHARMACOTHERAPY, 1995, 15 (06): : 687 - 692

← 1 2 3 4 5 →